Literature DB >> 146345

[A comparative clinical and pathological study on the classification and prognostic features of 57 thymomas. I. Microscopy and ultrastructural pathology (author's transl)].

H F Otto, H Hüsselmann.   

Abstract

Fifty-seven thymomas, defined as neoplasms of the epithelial-reticular framework cells of the thymus, were assessed in respect to histologic type, inclusive of there ultrastructural aspects. The median age of the 57 patients was 40.4 years, with a range of 2 1/2--72 years. All neoplasms were located in the anterior mediastinum. The tumours in 40 cases were encapsulated and without invasion of adjacent tissue or implants (equal to non-invasive thymomas). The tumors in 17 cases were invasive of adjacent tissue, particularly mediastinal pleura, pericard and trachea. Six of 57 patients (equal to 10.5%) with thymomas have had a thoracic and supraclavicular lymph node metastasis, and osteolytic metastases in the vertebrae and sternum. Thirty-seven (equal to 64.9%) were so-called lympho-epithelial, 7 (equal to 12.3%) pure epithelial, 4 (equal to 7.0%) atypical (or anaplastic) with granulomatous focuses, 3 (equal to 5.3%) carcinoid and one (equal to 1.8%) seminomatous tumors. One patient have had a thymic cyst as a tumor-like conditions of the thymus, and four patients (equal to 7.0%) have had a thymo-lipoma. The histologic type of thymoma had no proof value in predicting prognosis with the exception of the so-called atypical or anaplastic thymoma. The fine structural aspects of thymomas and the fine structural differential diagnosis of anterior mediastinal tumors are discussed.

Entities:  

Mesh:

Year:  1978        PMID: 146345     DOI: 10.1007/bf00305975

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  66 in total

1.  LEUKEMOGENIC THYMOMA: REPORT OF A UNIQUE CASE.

Authors:  J E ADAMS
Journal:  Am J Clin Pathol       Date:  1963-08       Impact factor: 2.493

2.  Epithelio-reticular cell thymoma with lymphocytic "emperipolesis." An ultrastructural study.

Authors:  A Llombart-Bosch
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 50-1976.

Authors: 
Journal:  N Engl J Med       Date:  1976-12-09       Impact factor: 91.245

4.  Teratoma of the anterior mediastinum in the group of military age; a study of 16 cases, and a review of theories of genesis.

Authors:  H G SCHLUMBERGER
Journal:  Arch Pathol (Chic)       Date:  1946-04

5.  Studies in a case of Cushing's syndrome due to an ACTH-producing thymic tumour.

Authors:  B L Pimstone; C J Uys; L Vogelpoel
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

6.  Epithelial nature of spindle-cell thymoma. An ultrastructural study.

Authors:  G D Levine; K G Bensch
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

7.  An unusual thymic tumour with a striated muscle (myoid) component (with a brief review of the literature on myoid cells).

Authors:  K Henry
Journal:  Br J Dis Chest       Date:  1972-10

8.  Hodgkin's disease of the thymus.

Authors:  R E Fechner
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

9.  Cervico-mediastinal thymic cyst with vocal cord paralysis.

Authors:  L L Bailey; R L Hilde; T R Smith; R J Thompson
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

10.  Tumors of the thymus.

Authors:  N B Friedman
Journal:  J Thorac Cardiovasc Surg       Date:  1967-02       Impact factor: 5.209

View more
  2 in total

1.  The epithelial framework of the thymus in normal and pathological conditions. Immunohistochemical demonstration of keratin in an autopsy series.

Authors:  T Löning; J Caselitz; H F Otto
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

2.  [Investigations on the ultrastructure of lympho-epithelial thymomas with special reference to "emperipolesis" (author's transl)].

Authors:  H F Otto
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.